DVYSR.ST STO
Devyser Diagnostics AB (publ)
1W: +6.0%
1M: -8.1%
3M: -5.8%
YTD: -48.8%
1Y: -62.8%
3Y: -27.7%
kr 54.10 ($5.39)
-0.70 (-1.28%)
Weekly Expected Move ±4.9%
kr 49
kr 52
kr 55
kr 57
kr 60
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$470M
-0.9% ▼
5Y CAGR: +44.6%
Total Liabilities
$115M
-7.5% ▼
5Y CAGR: +21.5%
Shareholders Equity
$354M
+1.5% ▲
5Y CAGR: +63.0%
Cash & Investments
$78M
-46.4% ▼
5Y CAGR: +56.2%
Total Debt
$89M
+51.3% ▲
5Y CAGR: +33.0%
Net Debt
$12M
+113.9% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $378M | $364M | $263M | $144M | $78M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $378M | $364M | $263M | $144M | $78M |
| Net Receivables | $26M | $33M | $45M | $75M | $67M |
| Inventory | $7M | $10M | $21M | $30M | $37M |
| Other Current Assets | -$214K | $33M | $45M | -$2M | $100K |
| Total Current Assets | $413M | $412M | $342M | $252M | $204M |
| Property, Plant & Equip. | $17M | $31M | $92M | $98M | $83M |
| Goodwill & Intangibles | $18M | $40M | $56M | $102M | $160M |
| Long-Term Investments | $2M | $89K | $100K | $200K | $1M |
| Other Non-Current Assets | $1K | -$149K | $0 | $0 | -$100K |
| Total Non-Current Assets | $44M | $89M | $168M | $222M | $265M |
| Total Assets | $457M | $501M | $510M | $474M | $470M |
| — Liabilities — | |||||
| Accounts Payable | $10M | $10M | $14M | $13M | $18M |
| Short-Term Debt | $0 | $100K | $0 | $100K | $14M |
| Deferred Revenue | $234K | $3M | $0 | $0 | $0 |
| Other Current Liabilities | $6M | $32M | $6M | $44M | $38M |
| Total Current Liabilities | $29M | $51M | $63M | $73M | $71M |
| Long-Term Debt | $0 | $555K | $600K | $300K | $38M |
| Other Non-Current Liab. | $797K | $2M | $5M | $7M | -$31M |
| Total Non-Current Liabilities | $11M | $18M | $62M | $52M | $44M |
| Total Liabilities | $40M | $69M | $125M | $125M | $115M |
| — Equity — | |||||
| Common Stock | $872K | $925K | $900K | $1M | $1M |
| Retained Earnings | -$33M | -$78M | -$130M | -$189M | -$195M |
| Accumulated OCI | -$440K | $844K | $0 | $600K | $3M |
| Total Stockholders Equity | $417M | $431M | $385M | $349M | $354M |
| Total Liabilities & Equity | $457M | $501M | $510M | $474M | $470M |
| — Key Metrics — | |||||
| Total Debt | $13M | $21M | $75M | $59M | $89M |
| Net Debt | -$365M | -$342M | -$188M | -$85M | $12M |
| Total Investments | $2M | $89K | $100K | $200K | $1M |